AbbVie faces setback as schizophrenia trial for emraclidine fails, but still has potential with other assets from Cerevel.

Nvidia's Q2 FY2025 results were strong, but Q3 may not exceed forecasts significantly, leading to a potential stock price ...

Grupo Financiero Galicia is benefiting from a rebound in private sector lending activity in Argentina. Market forecasts see ...

Coinbase Global (NASDAQ:COIN) is on track to extend gains for the seventh consecutive session as crypto-related shares ...

Savers Value Village, a major for-profit thrift retailer, shows modest revenue growth but mixed profitability, yet remains ...

Global Net Lease has a Dividend Payout ratio of 150% and has negative 72% price returns since IPO. Read our full bear case ...

Contango Ore, Inc. is transitioning from exploration to revenue generation, with its Manh Choh Mine producing gold and ...

The Magnificent Seven stocks’ growth rate is getting closer to that of the rest of the S&P 500 ( SP500 ).

Lucid Group reports strong Q3, yet losses continue to grow. Read why LCID stock is difficult to justify amid reliance on ...

Rolls-Royce's recent trading update continues to reflect progress, with developments in power systems and new markets looking ...

Declining inflation and potential changes in low-wage labor dynamics pose risks to Walmart's future performance. Read more on ...

As noted in today's Morning Lineup, the US dollar, among other assets, has continued to rise post-election. The Bloomberg ...